A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and overall safety and tolerability of
treatment with adjunctive JNJ-40411813 compared to placebo in patients with MDD with anxiety
symptoms being treated with an antidepressant.